Page last updated: 2024-10-31

midazolam and Elevated Cholesterol

midazolam has been researched along with Elevated Cholesterol in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pfefferkorn, JA1
Litchfield, J1
Hutchings, R1
Cheng, XM1
Larsen, SD1
Auerbach, B1
Bush, MR1
Lee, C1
Erasga, N1
Bowles, DM1
Boyles, DC1
Lu, G1
Sekerke, C1
Askew, V1
Hanselman, JC1
Dillon, L1
Lin, Z1
Robertson, A1
Olsen, K1
Boustany, C1
Atkinson, K1
Goosen, TC1
Sahasrabudhe, V1
Chupka, J1
Duignan, DB1
Feng, B1
Scialis, R1
Kimoto, E1
Bi, YA1
Lai, Y1
El-Kattan, A1
Bakker-Arkema, R1
Barclay, P1
Kindt, E1
Le, V1
Mandema, JW1
Milad, M1
Tait, BD1
Kennedy, R1
Trivedi, BK1
Kowala, M1

Other Studies

1 other study available for midazolam and Elevated Cholesterol

ArticleYear
Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distribution.
    Bioorganic & medicinal chemistry letters, 2011, May-01, Volume: 21, Issue:9

    Topics: Animals; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Hepatocytes; Hepta

2011